iShares Biotechnology ETF (NASDAQ:IBB) Shares Bought by PFG Investments LLC

PFG Investments LLC grew its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 118.4% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 4,397 shares of the financial services provider’s stock after buying an additional 2,384 shares during the period. PFG Investments LLC’s holdings in iShares Biotechnology ETF were worth $597,000 as of its most recent SEC filing.

Several other institutional investors also recently made changes to their positions in IBB. Vontobel Holding Ltd. grew its stake in shares of iShares Biotechnology ETF by 9.5% during the 1st quarter. Vontobel Holding Ltd. now owns 5,060 shares of the financial services provider’s stock valued at $659,000 after buying an additional 440 shares during the period. Blair William & Co. IL grew its stake in shares of iShares Biotechnology ETF by 9.7% during the 1st quarter. Blair William & Co. IL now owns 18,717 shares of the financial services provider’s stock valued at $2,439,000 after buying an additional 1,659 shares during the period. NewEdge Advisors LLC grew its stake in shares of iShares Biotechnology ETF by 11.7% during the 1st quarter. NewEdge Advisors LLC now owns 13,777 shares of the financial services provider’s stock valued at $1,796,000 after buying an additional 1,445 shares during the period. DCF Advisers LLC purchased a new stake in shares of iShares Biotechnology ETF during the 1st quarter valued at $912,000. Finally, Laurel Wealth Advisors Inc. grew its stake in shares of iShares Biotechnology ETF by 22.6% during the 1st quarter. Laurel Wealth Advisors Inc. now owns 3,019 shares of the financial services provider’s stock valued at $393,000 after buying an additional 557 shares during the period. 62.45% of the stock is owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Stock Up 1.4 %

Shares of iShares Biotechnology ETF stock opened at $137.79 on Thursday. The company has a fifty day moving average price of $136.42 and a 200 day moving average price of $128.75. iShares Biotechnology ETF has a twelve month low of $111.83 and a twelve month high of $141.16.

iShares Biotechnology ETF Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, March 27th. Investors of record on Friday, March 22nd were given a dividend of $0.126 per share. The ex-dividend date of this dividend was Thursday, March 21st. This represents a $0.50 dividend on an annualized basis and a yield of 0.37%.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.